PUGLISI, Soraya
 Distribuzione geografica
Continente #
NA - Nord America 2.531
EU - Europa 1.705
AS - Asia 1.009
SA - Sud America 311
AF - Africa 60
OC - Oceania 56
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.673
Nazione #
US - Stati Uniti d'America 2.386
IT - Italia 503
CN - Cina 311
IE - Irlanda 193
JP - Giappone 137
DE - Germania 135
SE - Svezia 134
ES - Italia 109
BR - Brasile 106
TR - Turchia 104
SG - Singapore 93
MX - Messico 89
FR - Francia 83
PL - Polonia 83
GB - Regno Unito 78
VN - Vietnam 70
AR - Argentina 68
IN - India 58
AU - Australia 54
CO - Colombia 50
RU - Federazione Russa 46
HK - Hong Kong 42
CA - Canada 39
UA - Ucraina 39
HU - Ungheria 35
GR - Grecia 33
RO - Romania 33
BE - Belgio 29
CL - Cile 27
KR - Corea 27
MY - Malesia 25
DZ - Algeria 24
NL - Olanda 22
FI - Finlandia 21
PT - Portogallo 21
RS - Serbia 20
EC - Ecuador 18
ID - Indonesia 18
IL - Israele 18
PE - Perù 16
VE - Venezuela 16
DK - Danimarca 15
TW - Taiwan 15
IQ - Iraq 13
IR - Iran 13
TH - Thailandia 13
AT - Austria 12
CH - Svizzera 12
TN - Tunisia 12
CZ - Repubblica Ceca 11
PH - Filippine 10
BG - Bulgaria 8
PK - Pakistan 8
SA - Arabia Saudita 8
ZA - Sudafrica 7
HR - Croazia 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
EG - Egitto 5
LK - Sri Lanka 5
SI - Slovenia 5
SY - Repubblica araba siriana 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
GT - Guatemala 4
NO - Norvegia 4
KE - Kenya 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
UZ - Uzbekistan 3
BB - Barbados 2
BY - Bielorussia 2
JO - Giordania 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MA - Marocco 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
EU - Europa 1
GH - Ghana 1
HN - Honduras 1
JM - Giamaica 1
LY - Libia 1
MT - Malta 1
MU - Mauritius 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.673
Città #
Chandler 378
Dublin 189
Fairfield 180
Redwood City 133
Ashburn 127
Torino 91
Houston 80
Ann Arbor 76
Beijing 75
Seattle 75
Woodbridge 72
Cambridge 70
Nyköping 66
Turin 66
Wilmington 64
Singapore 58
Medford 46
Dong Ket 44
Jacksonville 35
Princeton 34
Buenos Aires 31
Bogotá 30
Milan 27
Tokyo 26
San Diego 25
Istanbul 24
Hangzhou 22
Munich 22
Ankara 21
Okazaki 21
Rome 21
Shanghai 21
Würzburg 21
Pisa 20
Hong Kong 19
Los Angeles 19
Moscow 19
New York 19
Seoul 19
Budapest 18
Fremont 18
Guangzhou 17
Lima 16
Santiago 16
Curitiba 15
Dearborn 15
Helsinki 14
Soliera 14
London 13
Mexico 13
Mexico City 13
Sydney 13
Warsaw 13
Athens 12
Rochester 12
Uberlândia 12
Boston 11
Fukuoka 11
Florence 10
Gliwice 10
Jinan 10
Madrid 10
Paris 10
Szekszárd 10
Barcelona 9
Bucharest 9
Delhi 9
Guayaquil 9
Hebei 9
Córdoba 8
Osaka 8
Portland 8
San Jose 8
Taipei 8
Brisbane 7
Brno 7
Canberra 7
Florianópolis 7
Girona 7
Kuala Lumpur 7
Liège 7
Málaga 7
Nanjing 7
Padova 7
Polska 7
Puebla City 7
Silver Spring 7
Upper Marlboro 7
Zapopan 7
Amsterdam 6
Bad Zwischenahn 6
Belgrade 6
Berlin 6
Bozeman 6
Caracas 6
Changsha 6
Chengdu 6
Durham 6
Frankfurt am Main 6
Gumyojicho 6
Totale 2.968
Nome #
New perspectives for mitotane treatment of adrenocortical carcinoma 1.031
Hypertension and Acromegaly 669
Autonomous hypercortisolism: definition and clinical implications 582
Thyroid and colorectal cancer screening in acromegaly patients: Should it be different from that in the general population? 312
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. 261
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma 238
Analysis of BCLI, N363S and ER22/23EK polymorphisms of the glucocorticoid receptor gene in adrenal incidentalomas 230
Determination of salivary cortisol to assess time related changes of the adrenal response to stress in critically ill patients 152
May an adrenal incidentaloma change its nature? 134
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 109
Adrenal incidentalomas are tied to increased risk of diabetes: findings from a prospective study 109
Adrenocortical Carcinoma with Hypercortisolism. 107
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. 104
What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study 104
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma 99
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma 94
Mitotane: new facts for an old drug 90
Is Follow-up of Adrenal Incidentalomas Always Mandatory? 75
Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System 75
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 75
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer 74
PREOPERATIVE TREATMENT WITH METYRAPONE IN PATIENTS WITH CUSHING'S SYNDROME DUE TO ADRENAL ADENOMA. 68
Recovery of adrenal insufficiency is frequent after adjuvant mitotane therapy in patients with adrenocortical carcinoma 58
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA 53
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma 51
Molecular mechanisms of mitotane action in adrenocortical cancer based on in vitro studies 51
Prolonged adrenal insufficiency after the discontinuation of mitotane therapy 49
Levoketoconazole improves clinical signs and symptoms and patient-reported outcomes in patients with Cushing’s syndrome 48
Glucocorticoid Receptor Antagonism Upregulates Somatostatin Receptor Subtype 2 Expression in ACTH-Producing Neuroendocrine Tumors: New Insight Based on the Selective Glucocorticoid Receptor Modulator Relacorilant 47
How to improve effectiveness of pegvisomant treatment in acromegalic patients 43
Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation 42
Limited role of hair cortisol and cortisone measurement for detecting cortisol autonomy in patients with adrenal incidentalomas 42
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question 41
Long-term cardiometabolic outcome in patients with pituitary adenoma diagnosed in chilhood and adolescence 36
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma 31
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 29
Cardiometabolic Risk in Acromegaly: A Review With a Focus on Pasireotide 29
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 25
Acromegaly Is More Severe in Patients With AHR or AIP Gene Variants Living in Highly Polluted Areas 25
Multiple rebound-associated vertebral fractures after denosumab discontinuation: is prompt antiresorptive therapy always recommended, even when the risk of fracture seems low? A case report 25
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion 24
New findings on presentation and outcome of patients with adrenocortical cancer: results from a national cohort study 24
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 23
Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult ADHD Outpatients 23
Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study 23
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 23
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 20
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction 18
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma 18
Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy 17
Long-Term Consequences of Cushing's Syndrome: A Systematic Literature Review 17
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 16
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 16
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma 15
The management of post-operative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 13
Italian Guidelines For The Management Of Non-Functioning Benign And Locally Symptomatic Thyroid Nodules. 13
Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients’ Management 10
Intratumor microbiota modulates adrenocortical cancer responsiveness to mitotane 9
Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. 8
The Value of Local Therapies in Advanced Adrenocortical Carcinoma 7
International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects 5
Are comorbidities of patients with adrenal incidentaloma tied to sex? 3
Serendipitous Adrenal Hyperplasia in Patients Admitted to the Emergency Department for Suspected SARS-CoV-2 Infection is Linked to Increased Mortality 3
Totale 5.865
Categoria #
all - tutte 15.950
article - articoli 0
book - libri 0
conference - conferenze 653
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020402 5 6 2 22 11 35 48 73 84 42 31 43
2020/20211.048 54 56 94 63 65 53 73 109 74 112 111 184
2021/20221.259 99 72 91 102 131 75 78 91 88 108 185 139
2022/20231.577 126 114 54 128 135 271 99 123 205 84 120 118
2023/20241.410 122 171 90 138 131 124 110 135 50 86 128 125
2024/202539 39 0 0 0 0 0 0 0 0 0 0 0
Totale 5.865